Madrigal Pharmaceuticals

Perfil da empresa

Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company was founded in 2016 and is headquartered in West Conshohocken, Pennsylvania.

Descrição disponível em inglês.

Dados da empresa

Setor

Saúde

Indústria

Biotechnology

País

Estados Unidos

Sede

1001 Conshohocken State Road, 19428, West Conshohocken

Funcionários

915

Listagem

MDGL · NASDAQ

Moeda

USD

Site

madrigalpharma.com